Open Beta
TREN
MetriLume
TREN

US marketsBFRIW

SEC-sourced researchBeta

BFRIW

Biofrontera Inc.

Company comparison ↗

Data passport

CIK
0001858685
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Sep 14, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 37,321,000.0000 USD; December 2025: 41,705,000.0000 USD41.7M USD0 USD0December 2024December 2025
BFRIW · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202437,321,000.0000Mar 19, 2026
December 202541,705,000.0000Mar 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202541,705,000.0000-10,536,000.0000-13,361,000.000028,564,000.000018,084,000.0000Mar 19, 2026
December 202437,321,000.0000-17,759,000.0000-10,270,000.000022,101,000.000017,668,000.0000Mar 19, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

40/100
Profitability0
Growth62
Balance sheet37
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$41.71MJan 1, 2025 – Dec 31, 2025Mar 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$37.32MJan 1, 2024 – Dec 31, 2024Mar 19, 202610-K
Net incomeNetIncomeLoss-$10.54MJan 1, 2025 – Dec 31, 2025Mar 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$13.36MJan 1, 2025 – Dec 31, 2025Mar 19, 202610-K
Total assetsAssets$28.56MDec 31, 2025Mar 19, 202610-K
Total liabilitiesLiabilities$18.08MDec 31, 2025Mar 19, 202610-K

New filings

Explore methodology ↗